STEPHANIE CREWS: Open Payments
NPI 1568131142 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,399 in 97 payments from 18 companies in 2025. Trend: 2023 $1,766 · 2024 $2,425 · 2025 $2,399
Food & beverage: $2,399
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 7 | $484 |
| Galderma Laboratories, L.P. | 20 | $303 |
| Arcutis Biotherapeutics, Inc. | 9 | $302 |
| ABBVIE INC. | 15 | $274 |
| UCB, Inc. | 8 | $216 |
| LEO Pharma Inc. | 6 | $183 |
| Novartis Pharmaceuticals Corporation | 4 | $129 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $92 |
| Journey Medical Corporation | 3 | $71 |
| E.R. Squibb & Sons, L.L.C. | 4 | $68 |
Products named: DUPIXENT, Zoryve, Bimzelx, NEMLUVIO, RINVOQ, ADBRY, SKYRIZI, Sotyktu.
Industry payments across GA — which companies pay providers there.
